3 results
Approved WMOCompleted
The aim of this Phase II proof of concept study is to assess efficacy, haemodynamics and safety of Terguride vs. placebo in patients with pulmonary arterial hypertension (PAH). Having finished this proof-of-concept study it is intended that patients…
Approved WMOWill not start
Primary objective:To evaluate the efficacy of F13640 in spinal cord injury patients with moderate to severe central neuropathic pain, when administered for 12 weeks including a 7-day titration period. Main secondary objectives:To evaluate pain…
Approved WMOCompleted
The objective of this study is to assess the technical feasibility of the EsoFLIP dilation balloon in the treatment of achalasia